Clinical Trial Update: Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months

View source ↗

Summary

This completed trial evaluated whether procalcitonin can predict serious bacterial infection in infants under 3 months. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Neonatal Sepsis

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Fever, Bacterial Infection | Status: COMPLETED